Use of a cyclo-oxygenase 2 inhibitor for prophylaxis of cystoid macular oedema following cataract surgery: A randomized placebo-controlled trial

Clinical and Experimental Ophthalmology

Volumn 34, Issue 4, 2006, Pages 299-304

  Riley, Andrew F ^a   Wakely, Laura A ^a   Patel, Hussain Y ^a   Neveldsen, Bridget ^a   Purdie, Gordon L ^a   Wells, Anthony P ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Anti inflammatory agents; Cataract surgery; Cystoid macular oedema

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIGLAUCOMA AGENT; BETAMETHASONE SODIUM PHOSPHATE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; LITHIUM; METHOTREXATE; NEOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; RIFAMPICIN; TIMOLOL; WARFARIN;

ADULT; AGED; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG USE; EXTRACAPSULAR CATARACT EXTRACTION; FEMALE; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHACOEMULSIFICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA CYSTOID EDEMA; VISUAL ACUITY;

AGED; CATARACT EXTRACTION; CYCLOOXYGENASE 2 INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MACULA LUTEA; MACULAR EDEMA, CYSTOID; MALE; PROSPECTIVE STUDIES; PSEUDOPHAKIA; PYRAZOLES; SULFONAMIDES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 33746569533     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01213.x     Document Type: Article

References (23)

1. Riley AF, Malik TY, Grupcheva CN et al. The Auckland cataract study: co-morbidity, surgical techniques, and clinical outcomes in a public hospital service. Br J Ophthalmol 2002; 86: 185-90.
2. Irvine S. A newly defined vitreous syndrome according to recent concepts of the structure of the vitreous. Am J Ophthalmol 1953; 36: 599-619.
3. Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction. A fluorescein, funduscopic and angiographic study. Arch Ophthalmol 1966; 76: 646-61.
4. Ursell PG, Spalton DJ, Whitcup SM, Nussenblatt RB. Cystoid macular edema after phacoemulsification: Relationship to blood-aqueous barrier damage and visual acuity. J Cataract Refract Surg 1999; 11: 1492-7.
5. Hrynchak PS. Optical coherence tomography: An introduction to the technique and its use. Optom Vis Sci 2000; 77: 347-56.
6. Massin P, Vicaut E, Hsouchine B et al. Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 2001; 119: 1135-42.
7. Antcliff RJ, Stanford MR, Chauhan DS et al. Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology 2000; 107: 593-9.
8. Hirakawa H, Lijima H, Gohdo T et al. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa. Am J Ophthalmol 1999; 128: 185-91.
9. Hawkey CJ, Laine L, Simon T et al. Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: A multicentre, randomised, double blind study. Gut 2003; 52: 820-6.
10. Schein OD, Steinberg EP, Javitt JC et al. Variation in cataract surgery practice and clinical outcomes. Ophthalmology 1994; 101: 1142-52.
11. Rossetti L, Chaudhuri J, Dickersink K. Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis. Ophthalmology 1998; 105: 397-405.
12. Flach AJ, Jambol LM, Weinburg D et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 1991; 112: 514-19.
13. Flach AJ, Stegmen RC, Graham J et al. Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology 1990; 97: 1253-8.
14. Heier JS, Topping TM, Baumann W et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology 2000; 107: 2034-8.
15. Flach AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 1992; 36: 259-84.
16. Saunders DGB, Kraff C, Hutchins R et al. Aqueous penetration of oral and topical Indomethacin in humans. Arch Ophthalmol 1983; 101: 1614-16.
17. Klein R, Katzin HM, Yannuzzi LA. The effect of Indomethacin pretreatment on Aphakic Cystoid Macular Edema. Am J Ophthalmol 1979; 87: 487-9.
18. Hawkey CJ, Langman MJ. Non-steroidal anti-inflammatory drugs: Overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut 2003; 52: 600-8.
19. Wright JM. The double-edged sword of COX-2 selective NSAIDs. CMAJ 2002; 167: 1131-7.
20. Bombardier C, Laine L, Reicin A et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000; 343: 1520-8.
21. Watanabe M, Oshima Y, Emik K. Optical cross-sectional observation of resolved diabetic macular edema associated with vitreomacular separation. Am J Ophthalmol 2000; 129: 264-7.
22. Mittra RA, Borrillo JL, Dev S, Mieler WF, Koenig SB. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol 2000; 118: 912-17.
23. Squirrell D, Bhola R, Bush J et al. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol 2002; 86: 565-71.